{ "items" : [
    { "id" : "http://dbpedia.org/resource/Daiichi_Sankyo"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Daiichi Sankyo Company, Limited (第一三共株式会社, Daiichi Sankyō Kabushiki-kaisha) is a global pharmaceutical company and the second largest pharmaceutical company in Japan. It achieved JPY 1,148.2 billion in revenue in 2013. The company owns the American biotechnology company Plexxikon, the German biotechnology company U3 Pharma and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "Daiichi Sankyo Company, Limited" ] ,
        "http://xmlns.com/foaf/0.1/homepage" : [ "http://www.daiichisankyo.com/" ] ,
        "http://dbpedia.org/ontology/foundationPlace" : [ "http://dbpedia.org/resource/Tokyo",
          "http://dbpedia.org/resource/Japan" ] ,
        "http://dbpedia.org/ontology/foundingYear" : [ "2005Z" ] ,
        "http://dbpedia.org/ontology/industry" : [ "http://dbpedia.org/resource/Pharmaceutical_industry" ] ,
        "http://dbpedia.org/ontology/keyPerson" : [ "http://dbpedia.org/resource/Chief_executive_officer",
          "http://dbpedia.org/resource/Chairman",
          "http://dbpedia.org/resource/President_(corporate_title)" ] ,
        "http://dbpedia.org/ontology/location" : [ "http://dbpedia.org/resource/Chūō,_Tokyo",
          "http://dbpedia.org/resource/Tokyo",
          "http://dbpedia.org/resource/Japan",
          "http://dbpedia.org/resource/Nihonbashi" ] ,
        "http://dbpedia.org/ontology/numberOfEmployees" : [ 32229 ] ,
        "http://dbpedia.org/ontology/revenue" : [ "1.2006E10",
          "9.97852E11" ] ,
        "http://dbpedia.org/ontology/type" : [ "http://dbpedia.org/resource/Public_company"] } } }
